These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 1578935)
1. Early intensification followed by allo-BMT or auto-BMT or a second intensification in adult ALL: a randomized multicenter study. Bernasconi C; Lazzarino M; Morra E; Alessandrino EP; Pagnucco G; Resegotti L; Locatelli F; Ficarra F; Bacigalupo A; Carella AM Leukemia; 1992; 6 Suppl 2():204-8. PubMed ID: 1578935 [TBL] [Abstract][Full Text] [Related]
2. [Intensification chemotherapy followed by allogenieic and autologous bone marrow transplantation in acute non-lymphoblastic leukemia in children]. Ortega Aramburu JJ; Olivé Oliveras T; Javier Manchón G; Bastida Vila P; Sánchez C; Giralt López J Sangre (Barc); 1991 Feb; 36(1):7-14. PubMed ID: 1853274 [TBL] [Abstract][Full Text] [Related]
3. Allogeneic bone marrow transplantation vs aggressive post-remission chemotherapy for children with acute myeloid leukemia in first complete remission. A prospective study from the French Society of Pediatric Hematology and Immunology (SHIP). Michel G; Leverger G; Leblanc T; Nelken B; Baruchel A; Landman-Parker J; Thuret I; Bergeron C; Bordigoni P; Esperou-Bourdeau H; Perel Y; Vannier JP; Schaison G Bone Marrow Transplant; 1996 Feb; 17(2):191-6. PubMed ID: 8640165 [TBL] [Abstract][Full Text] [Related]
4. Induction therapy by frequent administration of doxorubicin with four other drugs, followed by intensive consolidation and maintenance therapy for adult acute lymphoblastic leukemia: the JALSG-ALL93 study. Takeuchi J; Kyo T; Naito K; Sao H; Takahashi M; Miyawaki S; Kuriyama K; Ohtake S; Yagasaki F; Murakami H; Asou N; Ino T; Okamoto T; Usui N; Nishimura M; Shinagawa K; Fukushima T; Taguchi H; Morii T; Mizuta S; Akiyama H; Nakamura Y; Ohshima T; Ohno R Leukemia; 2002 Jul; 16(7):1259-66. PubMed ID: 12094249 [TBL] [Abstract][Full Text] [Related]
5. Results of the vincristine, doxorubicin, and dexamethasone regimen in adults with standard- and high-risk acute lymphocytic leukemia. Kantarjian HM; Walters RS; Keating MJ; Smith TL; O'Brien S; Estey EH; Huh YO; Spinolo J; Dicke K; Barlogie B J Clin Oncol; 1990 Jun; 8(6):994-1004. PubMed ID: 2189958 [TBL] [Abstract][Full Text] [Related]
6. Bone marrow transplantation in 63 adult patients with acute lymphoblastic leukemia in first complete remission. Vey N; Blaise D; Stoppa AM; Bouabdallah R; Lafage M; Sainty D; Cowen D; Viens P; Lepeu G; Blanc AP Bone Marrow Transplant; 1994 Sep; 14(3):383-8. PubMed ID: 7994259 [TBL] [Abstract][Full Text] [Related]
7. DV-ICE, intensive induction and early transplantation for adult patients with acute lymphoblastic leukemia: a phase II study. Dudler C; Bargetzi M; Tichelli A; Gratwohl A; Passweg JR; Wernli M Eur J Haematol; 2009 Dec; 83(6):512-8. PubMed ID: 19614953 [TBL] [Abstract][Full Text] [Related]
8. Feasibility and results of bone marrow transplantation after remission induction and intensification chemotherapy in de novo acute myeloid leukemia. Catalan Group for Bone Marrow Transplantation. Sierra J; Brunet S; Grañena A; Olivé T; Bueno J; Ribera JM; Petit J; Besses C; Llorente A; Guardia R; Macía J; Rovira M; Badell I; Vela E; Díaz de Heredia C; Vivancos P; Carreras E; Feliu E; Montserrat E; Julía A; Cubells J; Rozman C; Domingo A; Ortega JJ J Clin Oncol; 1996 Apr; 14(4):1353-63. PubMed ID: 8648394 [TBL] [Abstract][Full Text] [Related]
9. Allogeneic or autologous bone marrow transplantation for acute lymphoblastic leukemia in first complete remission. Blaise D; Gaspard MH; Stoppa AM; Michel G; Gastaut JA; Lepeu G; Tubiana N; Blanc AP; Rossi JF; Novakovitch G Bone Marrow Transplant; 1990 Jan; 5(1):7-12. PubMed ID: 2404531 [TBL] [Abstract][Full Text] [Related]
10. Induction therapy with vincristine, adriamycin, dexamethasone (VAD) and intermediate-dose melphalan (IDM) followed by autologous or allogeneic stem cell transplantation in newly diagnosed multiple myeloma. Lokhorst HM; Sonneveld P; Cornelissen JJ; Joosten P; van Marwijk Kooy M; Meinema J; Nieuwenhuis HK; van Oers MH; Richel DJ; Segeren CN; Veth G; Verdonck LF; Wijermans PW Bone Marrow Transplant; 1999 Feb; 23(4):317-22. PubMed ID: 10100574 [TBL] [Abstract][Full Text] [Related]
11. Treatment of childhood acute lymphoblastic leukemia after the first relapse: curative strategies. Uderzo C; Dini G; Locatelli F; Miniero R; Tamaro P Haematologica; 2000 Nov; 85(11 Suppl):47-53. PubMed ID: 11268324 [TBL] [Abstract][Full Text] [Related]
12. Allogeneic and autologous bone marrow transplantation after consolidation therapy in high-risk acute myeloid leukemia in children. Towards a risk-oriented therapy. Ortega JJ; Díaz de Heredia C; Olivé T; Bastida P; Llort A; Armadans L; Torrabadella M; Massuet L Haematologica; 2003 Mar; 88(3):290-9. PubMed ID: 12651268 [TBL] [Abstract][Full Text] [Related]
13. High-dose chemotherapy with BEAC regimen and autologous bone marrow transplantation for intermediate grade and immunoblastic lymphoma: durable complete remissions, but a high rate of regimen-related toxicity. van Besien K; Tabocoff J; Rodriguez M; Andersson B; Mehra R; Przepiorka D; Dimopoulos M; Giralt S; Suki S; Khouri I Bone Marrow Transplant; 1995 Apr; 15(4):549-55. PubMed ID: 7655380 [TBL] [Abstract][Full Text] [Related]
14. [Intensive post-remission therapy in acute myeloid leukemia. Results of a prospective comparative study by the South Germany Hemoblastosis Group]. Hübner G; Link H; Schönrock-Nabulsi P; Wandt H; Gramatzki M; Löffler B; Fackler-Schwalbe I; Queisser W; Brack N; Geer T; Raab M; Ohl S; Schneider B; Schneider C; Freund M; Poliwoda H; Ehninger G Med Klin (Munich); 1996 Apr; 91 Suppl 3():26-32. PubMed ID: 8692115 [TBL] [Abstract][Full Text] [Related]
15. Efficacy of an early intensification treatment integrating chemotherapy, autologous stem cell transplantation and radiotherapy for poor risk primary mediastinal large B cell lymphoma with sclerosis. Cairoli R; Grillo G; Tedeschi A; Gargantini L; Marenco P; Tresoldi E; Barbarano L; Nosari AM; Morra E Bone Marrow Transplant; 2002 Mar; 29(6):473-7. PubMed ID: 11960265 [TBL] [Abstract][Full Text] [Related]
16. [Treatment of recurrence of acute myeloid leukemia in childhood. A retrospective analysis of recurrence in the AML-BFM-83 study]. Stahnke K; Ritter J; Schellong G; Beck JD; Kabisch H; Lampert F; Creutzig U Klin Padiatr; 1992; 204(4):253-7. PubMed ID: 1518261 [TBL] [Abstract][Full Text] [Related]
17. Role of allogenic bone marrow transplantation in adolescent or adult patients with acute lymphoblastic leukaemia or lymphoblastic lymphoma in first remission. De Witte T; Awwad B; Boezeman J; Schattenberg A; Muus P; Raemaekers J; Preijers F; Strijckmans P; Haanen C Bone Marrow Transplant; 1994 Nov; 14(5):767-74. PubMed ID: 7889010 [TBL] [Abstract][Full Text] [Related]
19. Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL 91 study. Associazione Italiana Ematologia Oncologia Pediatrica. Conter V; Aricò M; Valsecchi MG; Rizzari C; Testi A; Miniero R; Di Tullio MT; Lo Nigro L; Pession A; Rondelli R; Messina C; Santoro N; Mori PG; De Rossi G; Tamaro P; Silvestri D; Biondi A; Basso G; Masera G Haematologica; 1998 Sep; 83(9):791-9. PubMed ID: 9825576 [TBL] [Abstract][Full Text] [Related]
20. Allogeneic and autologous bone marrow transplantation in AML in first remission. The Spanish experience. Ortega JJ; Olivé T; Díaz de Heredia C; Coll MT; Bastida P; Massuet L Bone Marrow Transplant; 1996 Nov; 18 Suppl 2():53-8. PubMed ID: 8932800 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]